FDA approves MRSA drug tedizolid

The Food and Drug Administration has approved tedizolid phosphate for the treatment of adult acute bacterial skin and skin structure infections caused by susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus. Read More »